New Rapid Test Changes Brain Tumour Diagnosis

Doctors are using a new, faster way to identify brain tumours that could change the lives of many patients. The test, which was created by the Brain Tumour Research Centre of Excellence at the University of Nottingham, allows medical teams to get results while a patient is still on the operating table. According to The Guardian Health, this is a major improvement because it reduces the time needed for a diagnosis from eight weeks down to just two hours.

This development is important because brain tumours are a serious health issue. In the UK, they are the leading cause of cancer deaths for both children and adults under the age of 40. For many patients, time is very limited, and waiting months for test results can be a difficult and stressful experience. By getting answers quickly, doctors can start the right treatment much sooner, which may help save more lives.

Previously, doctors had to look at tumour samples under a microscope to identify them. This process was often slow and sometimes less precise. The new method uses a genomic test, which means it looks at the genetic code of the tumour. Small pieces of tissue are sent to a lab where they are placed into a special machine made by Oxford Nanopore. Inside this machine, DNA molecules pass through a tiny hole, known as a nanopore. This process reveals the unique genetic makeup of the tumour, giving doctors clear and accurate information very quickly.

Stuart Smith, a consultant neurosurgeon at Nottingham University Hospitals NHS Trust, helped lead the research team. He explained that having this detailed information while a patient is still in surgery is a game-changing moment for medicine. He noted that he is very proud of the team’s work, especially because it helps patients who do not have much time to wait for answers. This speed also means that some patients might be able to join clinical trials—which are special research studies to test new treatments—much earlier than before.

NHS England has already started using this new tool. According to The Guardian Health, the NHS is currently testing the method in five specialist centres across the country. These locations include Nottingham University Hospitals, University Hospitals Birmingham, Great Ormond Street Hospital, King’s College Hospital, and Newcastle Hospitals. Following this initial pilot phase, the plan is to bring the technology to other major cities, including Bristol, Oxford, Leeds, and Manchester.

Prof Frankie Swords, the NHS medical director, described the new test as a huge leap forward. She noted that it has the potential to completely change how brain tumours are diagnosed in the future. By removing the long wait for results, the NHS hopes to reduce the uncertainty that patients and their families face during such a difficult time.

This update follows earlier reports on the development of the test, which highlighted the urgent need for faster diagnostic tools. As the NHS continues to roll out this technology, the medical community remains hopeful that it will become a standard part of brain surgery. While the pilot program is still in its early stages, the ability to make fast, evidence-based decisions during an operation marks a significant step forward in modern healthcare. By combining advanced genetic science with practical surgical needs, researchers are providing doctors with the tools they need to give patients the best possible chance of recovery.